Atlas Trials

Placebo Controlled Study to Generate Data Characterising Clinical Events, Physiological Responses and Immune Responses

Clinical trial NCT02523287 · COMPLETED

Trial details

NCT number
NCT02523287
Sponsor
University Hospital, Ghent
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Safety Markers of Adjuvanted Influenza Vaccine
Start date
2014-10-02
Primary completion
2016-08-01
Enrollment
240

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.